Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Authors:
- Eike-Christian WamhoffEWEike-Christian Wamhoff
- Larance RonsardLRLarance Ronsard
- Jared FeldmanJFJared Feldman
- Grant A. KnappeGKGrant A. Knappe
- Blake M. HauserBHBlake M. Hauser
- Anna RomanovARAnna Romanov
- Evan LamELEvan Lam
- Kerri St. DenisKDKerri St. Denis
- Alejandro B. BalazsABAlejandro B. Balazs
- Aaron SchmidtASAaron Schmidt
Preprint
Abstract
Multivalent antigen display is a well-established principle to enhance humoral immunity. Protein-based virus-like particles (VLPs) are commonly used to spatially organize antigens. However, protein-based VLPs are limited in their ability to control valency on fixed scaffold geometries and are thymus-dependent antigens that elicit neutralizing B cell memory themselves, which can distract immune responses. Here, we investigated DNA origami as an alternative material for multivalent antigen display in vivo, applied to the receptor binding domain (RBD) of SARS-CoV-2 that is the primary antigenic target of neutralizing antibody responses. Icosahedral DNA-VLPs elicited neutralizing antibodies to SARS-CoV-2 in a valency-dependent manner following sequential immunization in mice, quantified by pseudo-and live-virus neutralization assays. Further, induction of B cell memory against the RBD required T cell help, but the immune sera did not contain boosted, class-switched antibodies against the DNA scaffold. This contrasted with protein-based VLP display of the RBD that elicited B cell memory against both the target antigen and the scaffold. Thus, DNA-based VLPs enhance target antigen immunogenicity without generating off-target, scaffold-directed immune memory, thereby offering a potentially important alternative material for particulate vaccine design.Keywords
All Related Versions
- Published version: Nature Communications, 15 (1), 1.
This publication has 97 references indexed in Scilit:
- Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodiesJournal of Experimental Medicine, 2013
- Marginal zone B cells: virtues of innate-like antibody-producing lymphocytesNature Reviews Immunology, 2013
- Merck Ad5/HIV induces broad innate immune activation that predicts CD8 + T-cell responses but is attenuated by preexisting Ad5 immunityProceedings of the National Academy of Sciences, 2012
- Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand T fh cells and promote germinal center inductionProceedings of the National Academy of Sciences, 2012
- A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionNature Medicine, 2010
- Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2Journal of Molecular Biology, 2008
- Folding DNA to create nanoscale shapes and patternsNature, 2006
- T-independent type II immune responses generate memory B cellsJournal of Experimental Medicine, 2006
- Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stagesNature, 1992
- Carrier-priming leads to hapten-specific suppressionNature, 1980